Skip to content
10-Q

Quarterly Report

Inspire Medical Systems, Inc. INSP

0001609550-26-000023

← back to feed
Filed
May 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 28, 2026 28.81M sh
Shares Diluted Q1 2026 · Mar 31, 2026 28.7M sh
Shares Diluted Q1 2026 · Mar 31, 2025 30.31M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $75.01M
Capex Q1 2026 · Mar 31, 2026 $9.73M
Capex Q1 2026 · Mar 31, 2025 $8.41M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $12.85M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$6.7M
Short Term Investments Q1 2026 · Mar 31, 2026 $184.9M
Short Term Investments Q1 2026 · Dec 31, 2025 $203.46M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $98.93M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $104.81M
Stockholders Equity Q1 2026 · Mar 31, 2026 $792.34M
Stockholders Equity Q1 2026 · Dec 31, 2025 $781.16M
Stockholders Equity Q1 2026 · Mar 31, 2025 $635.74M
Stockholders Equity Q1 2026 · Dec 31, 2024 $689.7M
Current Liabilities Q1 2026 · Mar 31, 2026 $89.42M
Current Liabilities Q1 2026 · Dec 31, 2025 $96.06M
Total Liabilities Q1 2026 · Mar 31, 2026 $119.04M
Total Liabilities Q1 2026 · Dec 31, 2025 $126.16M
Current Assets Q1 2026 · Mar 31, 2026 $566.82M
Current Assets Q1 2026 · Dec 31, 2025 $583.65M
Total Assets Q1 2026 · Mar 31, 2026 $911.38M
Total Assets Q1 2026 · Dec 31, 2025 $907.32M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.39
Eps Diluted Q1 2026 · Mar 31, 2025 $0.10
Eps Basic Q1 2026 · Mar 31, 2026 −$0.39
Eps Basic Q1 2026 · Mar 31, 2025 $0.10
Sga Expense Q1 2026 · Mar 31, 2026 $152.2M
Sga Expense Q1 2026 · Mar 31, 2025 $144.29M
Rd Expense Q1 2026 · Mar 31, 2026 $25.83M
Rd Expense Q1 2026 · Mar 31, 2025 $27.8M
Net Income Q1 2026 · Mar 31, 2026 −$11.29M
Net Income Q1 2026 · Mar 31, 2025 $2.99M
Operating Income Q1 2026 · Mar 31, 2026 −$1.12M
Operating Income Q1 2026 · Mar 31, 2025 −$1.49M
Gross Profit Q1 2026 · Mar 31, 2026 $176.91M
Gross Profit Q1 2026 · Mar 31, 2025 $170.61M
Revenue Q1 2026 · Mar 31, 2026 $204.58M
Revenue Q1 2026 · Mar 31, 2025 $201.32M